Document is current
Any future updates will be listed below
-
Authors
Roy, Shuvro
Huang, Yishang
Hu, Chen
Fitzgerald, Kathryn C.
Wang, Yujie
Newsome, Scott D. https://orcid.org/0000-0002-5284-4681
- License Information
-
More Information
Article History
Received: 12 March 2025
Revised: 12 April 2025
Accepted: 16 April 2025
First Online: 5 May 2025
Declarations
:
: S.D. Newsome received consultancy fees for scientific advisory boards from Biogen, Genentech, Inc., Bristol Myers Squibb, Novartis, and TG Therapeutics; study lead PI for a Roche clinical trial program; received research funding (paid directly to institution) from Biogen, Lundbeck, Roche, Genentech, Inc., Sanofi, National MS Society, The Stiff Person Syndrome Research Foundation, Department of Defense, and Patient-Centered Outcomes Research Institute. Y. Wang received consultancy fees from TG Therapeutics; received research funding (paid directly to institution) from Genentech, uniQure, and the National Institutes of Health. S. Roy has nothing to disclose. Y. Huang has nothing to disclose. C. Hu has nothing to disclose. KC. Fitzgerald has nothing to disclose.
: The study was approved by the Johns Hopkins University Institutional Review Board (IRB00154798) as part of an ongoing longitudinal observational study.
: Chart reviews and participant consent followed the IRB-approved protocol.
